Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,572 | 59,714 | 40,807 | 49,170 | 28,996 |
| Marketable Securities | 258,797 | 280,173 | 325,984 | 201,730 | 269,385 |
| Receivables | N/A | N/A | 108 | 5 | 248 |
| Other current assets | 243 | 243 | 243 | 243 | 0 |
| TOTAL | $301,282 | $350,770 | $377,565 | $259,449 | $306,354 |
| Non-Current Assets | |||||
| PPE Net | 8,480 | 8,148 | 4,698 | 2,251 | 1,508 |
| Investments And Advances | 35,744 | 37,495 | 39,326 | 0 | 0 |
| Intangibles | 3,736 | 3,736 | 3,736 | 12,536 | 12,536 |
| Other Non-Current Assets | 56,435 | 54,358 | 9,756 | 9,726 | 7,955 |
| TOTAL | $104,395 | $103,737 | $57,516 | $24,513 | $21,999 |
| Total Assets | $405,677 | $454,507 | $435,081 | $283,962 | $328,353 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,163 | 11,590 | 8,046 | 8,273 | 8,337 |
| Accrued Expenses | 30,322 | 32,354 | 31,369 | 25,304 | 24,460 |
| TOTAL | $43,485 | $43,944 | $39,415 | $33,577 | $32,797 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 45,138 | 44,495 | 6,301 | 784 | 981 |
| TOTAL | $46,526 | $46,081 | $1,670 | $2,776 | $2,918 |
| Total Liabilities | $90,011 | $90,025 | $41,085 | $36,353 | $35,715 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,630 | 45,563 | 45,306 | 45,053 | 41,315 |
| Common Shares | 46 | 45 | 45 | 41 | 41 |
| Retained earnings | -418,636 | -359,559 | -309,500 | -305,309 | -250,735 |
| Other shareholders' equity | -741 | 403 | 596 | 23,858 | 24,302 |
| TOTAL | $315,666 | $364,482 | $393,996 | $247,609 | $292,638 |
| Total Liabilities And Equity | $405,677 | $454,507 | $435,081 | $283,962 | $328,353 |